The global extracorporeal CO₂ removal market, valued at US$82.0 million in 2022, is anticipated to grow at a robust CAGR of 7.1% from 2023 to 2031, reaching an estimated US$153.3 million by the end of 2031. The market growth is primarily driven by the rising prevalence of chronic obstructive pulmonary disease (COPD) and increased awareness of acute respiratory distress syndrome (ARDS), coupled with ongoing technological advancements in extracorporeal CO₂ removal devices.
Unlock exclusive data and projections—get your market report sample from here:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39602
Market Introduction
Extracorporeal CO₂ removal devices are specialized medical systems that eliminate carbon dioxide from the blood without providing oxygenation, unlike extracorporeal membrane oxygenation (ECMO) systems. These devices typically include a pump console equipped with an isolating transformer and heater, offering both arteriovenous and venovenous access. Recent technological advancements have led to simpler, safer applications such as wire-reinforced dual-lumen catheters, pumps for venovenous support, and durable biocompatible membranes. However, the use of these devices requires highly skilled professionals to avoid complications like thrombus formation, bleeding, and lung hemolysis, which could restrain market growth.
Drivers of Market Growth
- Rise in Incidence of COPD:
Approximately 10.3% of the global population suffers from COPD, a major driver for extracorporeal CO₂ removal devices. In addition to eliminating CO₂, these devices enhance blood flow and provide critical lung support. Programs like ALung Technologies’ Hemolung Reference Centre have been instrumental in promoting these therapies worldwide. - Increasing Geriatric Population:
With the WHO predicting that 22% of the global population will be over 60 by 2050, age-related respiratory decline is becoming more prevalent. The elderly are particularly susceptible to COPD, necessitating advanced respiratory support solutions such as low-flow extracorporeal CO₂ removal systems designed for ultra-low volume mechanical ventilation.
Regional Outlook
North America currently holds the largest market share, driven by continuous infrastructure enhancements and high adoption rates during and after the COVID-19 pandemic. According to the American Lung Association, 11.7 million Americans contracted COPD in 2022. In Europe, an estimated 9.3% of the population suffers from COPD, while ARDS—a severe complication of COVID-19—continues to influence market dynamics. Meanwhile, in Asia Pacific, rising COPD incidences in countries like China (16.7% prevalence) and Australia (14.5% prevalence) are expected to drive market growth.
Analysis of Key Players
Leading companies are focusing on upgrading their extracorporeal CO₂ removal technologies through extensive R&D and clinical trials. Key market players include:
- ALung Technologies Inc.
- XENIOS AG
- Medica SpA
- Estor SpA
- Medtronic Plc
- Getinge AB
- Aferetica s.r.l.
These companies are profiled based on their company overview, product portfolio, strategic initiatives, and financial performance.
For Complete Report Details, Request Sample Copy from Here –
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39602
Key Developments
- May 2020: ALung Technologies, Inc. announced the development of its next-generation artificial lung—the Hemolung Respiratory Assist System (RAS)—designed for commercial use.
- November 2021: The Hemolung RAS received clearance from the US FDA, further validating its safety and efficacy in clinical applications.
Market Segmentation
Product:
Extracorporeal CO₂ Machines, Disposables, Gas Exchange Units, Access Cannulas
Application: Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Bridge to Transplant, Others
Access Type: Venovenous, Arteriovenous
End-user: Hospitals, Surgical Centers, Others
Regions Covered:
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Countries Covered:
U.S., Canada, Germany, U.K., France, Italy, Spain, China, India, Japan, Australia & New Zealand, Rest of Asia Pacific
Future Outlook
The extracorporeal CO₂ removal market is poised for continued growth, driven by ongoing innovations in device technology and rising demand from an aging population with increasing respiratory challenges. As manufacturers develop advanced, regulatory-compliant devices to enhance patient safety and treatment efficacy, the market is expected to offer significant opportunities for expansion in both developed and emerging economies.
Why This Report Matters?
This comprehensive report provides vital insights into the evolving landscape of the extracorporeal CO₂ removal market. By analyzing key trends, regional dynamics, and competitive strategies, stakeholders—including manufacturers, healthcare providers, and investors—can make informed decisions to capitalize on emerging opportunities and drive strategic growth in a competitive market.
Buy This Premium Research Report Now to Get Detailed Analysis:
https://www.transparencymarketresearch.com/checkout.php?rep_id=39602<ype=S
Frequently Asked Questions
What is the forecast period for the extracorporeal CO₂ removal market?
The market is forecasted from 2023 to 2031.
What are the main drivers of market growth?
Key drivers include the rising prevalence of COPD, increased awareness of ARDS, and the growing geriatric population, along with advancements in device technology.
Which region currently dominates the market?
North America holds the largest market share, supported by robust infrastructure and high adoption rates of extracorporeal CO₂ removal devices.
What are the primary product segments covered in this market?
The market is segmented into extracorporeal CO₂ machines, disposables, gas exchange units, and access cannulas, with further categorization by application and access type.
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
